Companies: 10,795·Total market cap: $144.5T
Twist Bioscience Corporation

Twist Bioscience Corporation

TWSTNASDAQHealthcare● Active
$68.83
$-0.39(-0.56%)
Market Cap$4.3B
P/E Ratio
52W High$72.99
52W Low$23.3
Overview

Twist Bioscience Corporation (TWST) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

twst · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 13 Wall Street analysts in the past 3 months

SellBuy

Buy

13 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
11
Hold
1
Sell
1
Strong Sell
0
Total: 13 · Buy rate: 84.6%

12-Month Price Target

High

$80.00

Consensus

$64.40

-6.7% upside

Low

$52.00

Median: $65 · Last Close: $69.00

The Twist Bioscience Corporation (TWST) analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month TWST price target is $64.40, representing -6.7% upside from the current price of $69.00.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $64 (-6.7%)

Consensus Target

$64.40

-6.7% upside

High Target

$80

15.9%

Low Target

$52

-24.6%

Current Price

$69.00

as of today

Based on analyst price targets, the TWST stock price prediction for the next 12 months ranges from $52 to $80. The consensus TWST price forecast of $64.40 implies -6.7% upside from the current price of $69.00.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$72.455.00%

1-day model range: $71.87–$73.03. Peak: $73.03 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$89+28.3%
2028$104+50.2%
2029$114+65.5%
2030$121+75.6%
2031+82.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

79%0%21%
11Buy
0Neutral
3Sell
RSI (14)77.2Overbought
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · TWST · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$70.93SELL
MA 10$68.74BUY
MA 20$61.42BUY
MA 50$57.70BUY
MA 100$51.96BUY
MA 200$41.15BUY
Current $TWST · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$69.75SELL
EMA 10$67.74BUY
EMA 20$64.18BUY
EMA 50$58.50BUY
EMA 100$52.56BUY
EMA 200$46.32BUY
Current $TWST · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Leerink Partners2026-05-05
Upgrade ↑
Market PerformOutperform
Barclays2026-05-05
Maintains
OverweightOverweight
Guggenheim2026-05-05
Maintains
BuyBuy
Baird2026-05-05
Maintains
OutperformOutperform
Barclays2026-04-14
Maintains
OverweightOverweight
Evercore ISI Group2026-04-06
Maintains
OutperformOutperform
Guggenheim2026-03-30
Maintains
BuyBuy
Evercore ISI Group2026-02-03
Maintains
OutperformOutperform
Barclays2026-02-03
Maintains
OverweightOverweight
Guggenheim2026-01-26
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Twist Bioscience Corporation (TWST) stock. Of the recent 80 rating actions, 3 were upgrades and 2 were downgrades. 13 analysts currently cover TWST.

Analyst Recommendation Trends

Buy ratings14↑ +3
Hold ratings00
Sell ratings00

TWST analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$447M

↓ 25.5% YoY

Revenue Next Year

$520M

↑ 16.3% YoY

EPS This Year

$-2.05

EPS Next Year

$-1.37

↓ 33.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TWST EPS of $-2.05 for the current fiscal year, based on estimates from 5 analysts. The TWST revenue forecast is $447M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The TWST stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TWST price target is $64.40 (-6.7% upside), with an analyst consensus of Buy.

The TWST short-term stock prediction for tomorrow is $72.45 (+5.00%). The TWST stock price prediction for 2027 estimates an average of $89. The TWST stock prediction for 2030 projects a range of $111–$132.

Twist Bioscience Corporation trades on NASDAQ under the ticker TWST. The TWST stock outlook for 2027 is broadly positive, supported by a Buy consensus among 85% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

TWST forecast · 8 questions

According to 13 Wall Street analysts, the average 12-month TWST price target is $64.40, with a high forecast of $80.00 and a low of $52.00. The median price target is shown in the chart above when available. This implies -6.7% potential upside from the current price of $69.00.

TWST price targetWhat is TWST price targetTWST analyst price targetTWST 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.